When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration

por Michalska, Patrycja, León, Rafael
Publicado 2020

Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease

por Duarte, Pablo, Michalska, Patrycja, Crisman, Enrique, Cuadrado, Antonio, León, Rafael
Publicado 2022

Enantioselective Synthesis and Pharmacological Evaluation of Aza-CGP37157–Lipoic Acid Hybrids for the Treatment of Alzheimer’s Disease

por Cores, Ángel, Michalska, Patrycja, Pérez, José Miguel, Crisman, Enrique, Gómez, Clara, Villacampa, Mercedes, Menéndez, José Carlos, León, Rafael
Publicado 2022

A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors

por Corman, Alba, Kanellis, Dimitris C., Michalska, Patrycja, Häggblad, Maria, Lafarga, Vanesa, Bartek, Jiri, Carreras-Puigvert, Jordi, Fernandez-Capetillo, Oscar
Publicado 2021

Perspective of Internet Poker Players on Harm-Reduction Strategies: A Cross-Sectional Study

por Michalska, Patrycja, Chatton, Anne, Penzenstadler, Louise, Izdebski, Paweł, Jeannot, Emilien, Simon, Olivier, Dufour, Magali, Rochat, Lucien, Lischer, Suzanne, Khazaal, Yasser
Publicado 2020

Bisavenathramide Analogues as Nrf2 Inductors and Neuroprotectors in In Vitro Models of Oxidative Stress and Hyperphosphorylation

por Cores, Ángel, Abril, Sheila, Michalska, Patrycja, Duarte, Pablo, Olives, Ana I., Martín, M. Antonia, Villacampa, Mercedes, León, Rafael, Menéndez, J. Carlos
Publicado 2021

Antioxidant, Anti-inflammatory and Neuroprotective Profiles of Novel 1,4-Dihydropyridine Derivatives for the Treatment of Alzheimer’s Disease

por Michalska, Patrycja, Mayo, Paloma, Fernández-Mendívil, Cristina, Tenti, Giammarco, Duarte, Pablo, Buendia, Izaskun, Ramos, María Teresa, López, Manuela G., Menéndez, J. Carlos, León, Rafael
Publicado 2020

Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation

por González-Ruiz, Víctor, Cores, Ángel, Martín-Cámara, Olmo, Orellana, Karen, Cervera-Carrascón, Víctor, Michalska, Patrycja, Olives, Ana I., León, Rafael, Martín, M. Antonia, Menéndez, J. Carlos
Publicado 2021

Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer’s disease

por Gameiro, Isabel, Michalska, Patrycja, Tenti, Giammarco, Cores, Ángel, Buendia, Izaskun, Rojo, Ana I., Georgakopoulos, Nikolaos D., Hernández-Guijo, Jesús M., Teresa Ramos, María, Wells, Geoffrey, López, Manuela G., Cuadrado, Antonio, Menéndez, J. Carlos, León, Rafael
Publicado 2017

The angiotensin‐(1‐7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation

por Romero, Alejandra, San Hipólito‐Luengo, Álvaro, Villalobos, Laura A., Vallejo, Susana, Valencia, Inés, Michalska, Patrycja, Pajuelo‐Lozano, Natalia, Sánchez‐Pérez, Isabel, León, Rafael, Bartha, José Luis, Sanz, María Jesús, Erusalimsky, Jorge D., Sánchez‐Ferrer, Carlos F., Romacho, Tania, Peiró, Concepción
Publicado 2019

Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades

por Herrera-Arozamena, Clara, Estrada-Valencia, Martín, López-Caballero, Patricia, Pérez, Concepción, Morales-García, José A., Pérez-Castillo, Ana, Sastre, Eric del, Fernández-Mendívil, Cristina, Duarte, Pablo, Michalska, Patrycja, Lombardía, José, Senar, Sergio, León, Rafael, López, Manuela G., Rodríguez-Franco, María Isabel
Publicado 2022

Nrf2 Plays a Protective Role Against Intravascular Hemolysis-Mediated Acute Kidney Injury

por Rubio-Navarro, Alfonso, Vázquez-Carballo, Cristina, Guerrero-Hue, Melania, García-Caballero, Cristina, Herencia, Carmen, Gutiérrez, Eduardo, Yuste, Claudia, Sevillano, Ángel, Praga, Manuel, Egea, Javier, Cannata, Pablo, Cortegano, Isabel, de Andrés, Belén, Gaspar, María Luisa, Cadenas, Susana, Michalska, Patrycja, León, Rafael, Ortiz, Alberto, Egido, Jesús, Moreno, Juan Antonio
Publicado 2019

MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species

por VERA-PUENTE, OLGA, RODRIGUEZ-ANTOLIN, CARLOS, SALGADO-FIGUEROA, ANA, MICHALSKA, PATRYCJA, PERNIA, OLGA, REID, BRETT M., ROSAS, ROCÍO, GARCIA-GUEDE, ALVARO, SACRISTÁN, SILVIA, JIMENEZ, JULIA, ESTEBAN-RODRIGUEZ, ISABEL, MARTIN, M. ELENA, SELLERS, THOMAS A., LEÓN, RAFAEL, GONZALEZ, VÍCTOR M., DE CASTRO, JAVIER, DE CACERES, INMACULADA IBANEZ
Publicado 2018